Oncology Pharmaceuticals Market in India 2014

  • Product Code:
  • Published Date:
    17 Jul 2021
  • Region:
  • Pages:
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More


Market Overview:

Netscribes' latest market research report titled Oncology Pharmaceutical Market in India 2014 highlights the analysis of the drivers and explains the factors for growth of the industry. Increasing number of cancer cases are the key drivers of this market. Lung, stomach, colon and breast cancer cause the maximum number of cancer deaths each year. Pharmaceutical companies are progressively increasing R&D expenditure on cancer vaccines. The growing number of patients seeking treatment for cancer has made hospitals realize that cancer treatment is an important area for growth. Gleevec, Mabthera, Iressa, Avastin, Grafeel, Soliris and Herceptin are the top selling cancer drugs in the Indian market.

Alternative therapies such as cancer gene therapy and cancer cell therapy are increasingly becoming popular in cases where conventional therapies have failed. Combination therapies are being increasingly used in cancer treatments. Some challenges faced by the industry are the internal competition between large pharmaceutical companies. Another challenge is the penetration of Oncological drugs in rural areas which is very low. Various government initiatives have been undertaken to reduce the drug prices and various tax reforms and control programs are promoting the growth of the market as well. Manufacture of generic oncology drugs will help the pharmaceutical manufacturer gain a competitive advantage over others in a highly competitive pharma market. Companies should focus on development of new molecules in order to prolong the longevity of a blockbuster drug in the market.

Geography Analysis:

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook


Slide 1: Executive Summary

Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 - Dec 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 - Jul 2013), Exchange Rate: Half Yearly (Oct 2013 - Mar 2014)
Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2010-11, 2011-12, 2012-13, 2013-14), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)

Slide 5-6: Types of Chemotherapy drugs

Market Overview
Slide 7-9: Global Oncology Pharmaceutical Market - Overview, Market Size & Growth (2013-2018e), Indian Oncology Pharmaceutical Market - Overview, Market Size & Growth (2013-2018e), Regions with high cancer prevalence, Top 5 cancer's in India

Slide 10-11: Region wise Exports, Total Exports, Region wise Imports, Total Imports

Value Chain
Slide 12-13: Market Value Chain Analysis

Drivers & Challenges
Slide 14: Drivers and Challenges - Summary
Slide 15-19: Drivers
Slide 20-22: Challenges

Government Initiatives
Slide 23: Government Initiatives - Summary
Slide 24: Helping the Market to grow
Slide 25: National List of Essential Medicines (NLEM), Jan Aushadhi Stores (JAS)
Slide 26-27: cancer awareness programmes
Slide 28: Reduction in Excise Duties

Slide 29: Licensing and registration of pharmaceuticals
Slide 30: Various other regulatory frameworks
Slide 31-33: Patent Approvals

Competitive Landscape
Slide 34: Porter's Five Forces Analysis
Slide 35: Public Trading Comparables, Top 3 Companies
Slide 36-38: Competitive Benchmarking, Key Ratios of Top 3 Companies - Operational Basis (FY 2013)
Slide 39: Competitive Benchmarking, Key Ratios of Top 3 Companies - Financial Basis (FY 2013)
Slide 40-75: Major Public Players
Slide 76-85: major Private Players

Recent Developments
Slide 86-87: Recent Developments

Strategic Recommendation
Slide 88: Strategic recommendation

Slide 89: Key Ratios Description
Slide 90: Sources of Information
Please enter your personal details below
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Public Companies
1. Sanofi India Ltd.
2. Cipla Ltd.
3. Dr. Reddy's Laboratories Ltd.
4. GlaxoSmithKline Pharmaceuticals Ltd.
5. Novartis India Ltd.
6. Merck Ltd.
7. Pfizer Ltd.
8. Ranbaxy Laboratories Ltd.

Private Companies
9. Johnson and Johnson Ltd.
10. Roche Pharmaceuticals Pvt. Ltd.
Please enter your personal details below
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports